Show simple item record

dc.contributor.authorHo, W L
dc.contributor.authorComber, H
dc.contributor.authorHill, A D K
dc.contributor.authorMurphy, G M
dc.date.accessioned2011-04-07T08:52:48Z
dc.date.available2011-04-07T08:52:48Z
dc.date.issued2009-03-05
dc.identifier.citationMalignant melanoma and breast carcinoma: a bidirectional correlation. 2009: Ir J Med Scien
dc.identifier.issn1863-4362
dc.identifier.pmid19263184
dc.identifier.doi10.1007/s11845-009-0297-5
dc.identifier.urihttp://hdl.handle.net/10147/127624
dc.description.abstractBACKGROUND: Epidemiologic and genetic studies have suggested a bidirectional association between breast carcinoma (BC) and malignant melanoma (MM). OBSERVATION: We present a series of patients with MM and BC detected in our department within a span of 6 months, raising concerns for the high associations between the two malignancies. This led us to match the concordance of the two tumours in the National Irish Cancer Registry. CONCLUSION: The national figures provide evidence of a link between BC and MM. We recommend increased awareness among clinicians leading to more detailed surveillance of both second primary tumours. All MM patients with a family history of BC should be referred to a breast clinic. Women above the age of 40 with MM should undergo annual mammography and those less than 40 may be better evaluated with a breast MRI. All breast cancer patients should be made aware of the significance of changing moles and those with suspicious lesions referred to a dermatologist for evaluation.
dc.languageENG
dc.titleMalignant melanoma and breast carcinoma: a bidirectional correlation.en
dc.typeArticle In Pressen
dc.contributor.departmentDepartment of Dermatology, Beaumont Hospital, Dublin 9, Ireland, drwlho@yahoo.com.en
dc.identifier.journalIrish journal of medical scienceen
dc.description.provinceLeinster
html.description.abstractBACKGROUND: Epidemiologic and genetic studies have suggested a bidirectional association between breast carcinoma (BC) and malignant melanoma (MM). OBSERVATION: We present a series of patients with MM and BC detected in our department within a span of 6 months, raising concerns for the high associations between the two malignancies. This led us to match the concordance of the two tumours in the National Irish Cancer Registry. CONCLUSION: The national figures provide evidence of a link between BC and MM. We recommend increased awareness among clinicians leading to more detailed surveillance of both second primary tumours. All MM patients with a family history of BC should be referred to a breast clinic. Women above the age of 40 with MM should undergo annual mammography and those less than 40 may be better evaluated with a breast MRI. All breast cancer patients should be made aware of the significance of changing moles and those with suspicious lesions referred to a dermatologist for evaluation.


This item appears in the following Collection(s)

Show simple item record